Predictions
Anebulo Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.74
16.04.24
16.04.24
-
16.04.25
16.04.25
0.73%
13.05.24
13.05.24
Marinus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.22
15.04.24
15.04.24
-
15.04.25
15.04.25
7.38%
28.04.24
28.04.24
D-wave Quantum Inc.
Start price
Target price
Perf. (%)
€1.45
15.04.24
15.04.24
€3.00
22.03.25
22.03.25
12.18%
17.04.24
17.04.24
Monopar Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.71
15.04.24
15.04.24
-
15.04.25
15.04.25
-21.28%
20.05.24
20.05.24
Applied Therapeutics Inc
Start price
Target price
Perf. (%)
€4.72
15.04.24
15.04.24
-
16.03.25
16.03.25
-20.90%
23.05.24
23.05.24
Marinus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.50
15.04.24
15.04.24
-
15.04.25
15.04.25
-12.67%
27.04.24
27.04.24
Coupang Inc.
Start price
Target price
Perf. (%)
€20.48
15.04.24
15.04.24
€35.00
31.12.25
31.12.25
-0.07%
15:58
15:58
Could be very worthwhile Investment >20% year
Addex Therapeutics Sa
Start price
Target price
Perf. (%)
€22.40
15.04.24
15.04.24
€35.00
29.03.26
29.03.26
-69.87%
29.04.24
29.04.24
Could be very worthwhile Investment >20% year
Aap Implantate AG
Start price
Target price
Perf. (%)
€0.79
15.04.24
15.04.24
€2.00
15.04.25
15.04.25
49.04%
15:22
15:22
Top 10 in its market
Revenue growth >5% per year expected
Future proof or reliable business model
Higher EBIT margin than peer group
D-wave Quantum Inc.
Start price
Target price
Perf. (%)
€1.54
15.04.24
15.04.24
-
15.04.25
15.04.25
-13.13%
27.04.24
27.04.24
Could be worthwhile Investment >10% per year
Normal challenges to pay loans and raise capital
EBIT growth >5% per year expected
High dividend yield expected
Coupang Inc.
Start price
Target price
Perf. (%)
€20.35
15.04.24
15.04.24
€33.00
15.04.25
15.04.25
6.41%
27.04.24
27.04.24
positive Cash Flow expected
Could be worthwhile Investment >10% per year
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
D-wave Quantum Inc.
Start price
Target price
Perf. (%)
€1.50
14.04.24
14.04.24
€1.00
14.04.25
14.04.25
12.53%
17.04.24
17.04.24
Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Globe Life Inc.
Start price
Target price
Perf. (%)
€55.50
14.04.24
14.04.24
-
14.04.25
14.04.25
27.03%
27.04.24
27.04.24
Could be worthwhile Investment >10% per year